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Spinal cord injury (SCI) is a catastrophic event that can profoundly affect a patient’s life, with 
far-reaching social and economic effects. A consequential sequence of SCI is the significant 
neurological or psychological deficit, which obviously contributes to the overall burden of this 
condition. To date, there is no effective treatment for SCI. Therefore, developing novel 
therapeutic strategies for SCI is highly prioritized. Flavonoids, one of the most numerous and 
ubiquitous groups of plant metabolites, are the active ingredients of traditional Chinese medicine 
(TCM) such as Scutellaria baicalensis Georgi (Huang Qin) or Ginkgo biloba(Ying Xin).Accumulated 
research data show that flavonoids possess a range of key pharmacological properties such as 
anti-inflammatory, antioxidant, anti-tumor, anti-viral, anti-cardiovascular disease, 
immunomodulatory, and neuroprotective effects. Based on this, the flavonoids show therapeutic 
potential for SCI diseases. In the following article, we will review the pharmacological properties 
of different types of flavonoids for treatment of spinal cord injury diseases, and potential 



























In modern society, the estimated annual global incidence of spinal cord injury (SCI) is 
approximately 15–40 cases per million and is increasing (Singh et al., 2014; Sekhon and Fehlings, 
2001). SCI is a catastrophic event that can profoundly affect a patient’s life, with far-reaching 
social and economic effects(Sekhon and Fehlings, 2001). A consequence of SCI is the significant 
neurological or psychological deficit, which obviously contributes to the overall burden of this 
condition (Evaniew et al., 2015). Along with the development of neurobiology, materials science, 
pharmacology, and other related sciences, great progress has been made in the prevention and 
treatment of SCI. 
Significant progress has been made to relieve the symptoms of SCI and the suffering of 
patients, which are achieved by preventing injury progression (Silva et al., 2014; Zhang et al., 
2016). At present, in the early phase, the conventional treatment of spinal cord injury in clinic is 
surgical therapy combined with high doses of methylprednisolone (MP). The surgical procedures 
are able to decompress the spinal cord and restore the normal anatomy of the spine and 
stability(Ahuja, Martin, and Fehlings, 2016).Although MP has many advantages such as 
maintaining the blood-spinal cord barrier, enhancing spinal cord blood flow, and limiting the 
inflammatory response(Suberviola et al., 2008), potential harms of MP include risks of infections 
and gastrointestinal bleeding, potentially leading to increased mortality. Therefore, most current 
guidelines do not recommend routine administration of MP for acute SCI(Hurlbert et al., 2015; 
Hurlbert, 2014; Walters et al., 2013). Meanwhile, various other novel strategies for SCI repair 
have emerged and received considerable research attention, including drug therapy such as 
Gangliosides(Chinnock and Roberts, 2005), Erythropoietin (EPO)(Nekoui et al., 2015), 
Minocycline(Aras et al., 2015), Vitamin B12(Petchkrua et al., 2003), Tacrolimus(Pan et al., 2013); 
cell therapy such as transplantation of neural stem cells(Cheng et al., 2016), bone 
marrow-derived mesenchymal stem cells(Yousefifard et al., 2016), adipose-derived mesenchymal 
stem cells(Kim et al., 2015), Schwann cells(Oraee-Yazdani et al., 2016), olfactory ensheathing 
cells(Li et al., 2015); gene modification technique therapy such as nerve growth factor (NGF)(Zhai 
et al., 2015), neurotrophin-3(Hanna et al., 2016), brain-derived neurotrophic factor (BDNF)(Wang, 
Liao, and Li, 2010), glial cell line-derived neurotrophic factor (GDNF)(Chou et al., 2014),or ciliary 
neurotrophic factor(Abbaszadeh et al., 2015).However, it is worth noting that most of the 
treatments are still at the research stage, and are not ready for use in the clinic. Thus, the 
treatment of SCI is currently a significant challenge in the clinic and in research around the world. 
To date, there is no majorly effective treatment for SCI(Zhao et al., 2011). 
As a productive natural resource for drug discovery, Traditional Chinese Medicine (TCM),has 
many thousands of years of history in clinical applications in China and other Asian countries, 
plays a role in complementary and alternative medical systems, and has an advantage for 
treatment of SCI due to a large number of experimental studies(Liu et al., 2015; Boots, Haenen, 
and Bast, 2008; Manach et al., 2005). Although TCM therapy could not replace surgical 
procedures, it could be play a supportive role in treating SCI. Scutellaria baicalensis Georgi 
(Chinese name Huang Qin), Quercetin(Chinese name Hu Pi), Puerarin (Chinese name Ge Gen), 
Safflower Yellow (Chinese name Hong Hua Huang), -Epigallocatechin gallate (Chinese name Er 
Cha Su), Anthocyanins (Chinese name Hua Qing Su), Ginkgo biloba (Chinese name Ying Xin), and 
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numerous others. TCM has provided classic herbal medicine for treating spinal cord injury 
diseases in the clinic for many years. It was found that the main active components are 
flavonoids by using modern pharmacological discovery. Flavonoids,one of the most numerous 
and ubiquitous groups of plant metabolites, have anti-inflammatory, antioxidant, 
neuroprotective physiological activity as demonstrated in experimental studies. In addition, a 
number of studies have found that flavonoids have therapeutic potential in SCI. However, the 
molecular mechanisms involved the effects shown by TCM still remain unclear, and it can be 
challenging to systematically identify them using modern pharmacological and biochemical 
techniques(Liu et al., 2015).In the following paragraphs, we will review the pharmacological 
actions of different types of flavonoids for the treatment of spinal cord injury diseases, and some 
potential underlying biochemical mechanisms of action will also be described. 
 
Pathophysiology of SCI 
Patients with spinal cord injury often experience severe loss of function and a profoundly 
impaired quality of life. More and more research has focused on elucidating the mechanisms and 
complex pathophysiologic processes of SCI. Pathophysiological events occurring after SCI include 
a primary mechanical injury and a secondary injury. 
A primary mechanical injury often results from a mechanical impact to the spine, 
concomitant with or followed by compression, contusion, stretching or kinking of the spinal 
cord(Stahel, VanderHeiden, and Finn, 2012).This phase refers to the immediate post-injury period, 
and this process is inevitable. The damage level of this stage is very difficult to control, which 
depends on the intensity of force and the compression time on the spinal cord(DeVivo, Go, and 
Jackson, 2002). Therefore, we have no treatment for a primary mechanical injury. 
A secondary injury mediated by multiple processes after the initial trauma(Amar and Levy, 
1999). The time course of this process ranges from minutes to weeks following SCI and leads to 
further damage. The outcomes of SCI depend mainly on the extent of secondary damage 
produced by a series of cellular and molecular events such as inflammation(Popovich, Wei, and 
Stokes, 1997), free radical production(Hall, 1993, 1993), vascular events(Mautes et al., 2000), 
glutamate excitotoxicity(Dong and Wang, 1998), and apoptosis(Liu et al., 1997), which inevitably 
induce neuronal and glial cell death at and beyond the site of injury(Zhao et al., 2011).  
The secondary stage can cause a series of events, for example, an inflammatory response 
induces higher extravasation of leukocytes and further tissue damage of the surrounding original 
injury site(Yang et al., 2005; Donnelly and Popovich, 2008).Moreover, several studies have 
demonstrated that inflammation also plays an important role in blocking neural tissue repair; free 
radical formation and lipid peroxidation cause oxidative death of the spinal cord neurons and 
reduce spinal cord blood flow that leads to edema and a continuation of the inflammatory 
response(Toborek et al., 1999); vascular changes lead to edema, necrosis, and ischemia(Bareyre 
and Schwab, 2003); glutamate excitotoxicity leads to further neuronal cell death; apoptosis can 
cause programmed cell death of neurons, oligodendrocytes, microglia, and, perhaps, astrocytes 
after SCI(Beattie, Farooqui, and Bresnahan, 2000). Moreover, this process will last for a long 
time(Wilson and Fehlings, 2014). Without immediate treatment, SCI will lead to neurological 
impairments in motor function, affect the function of brain regions, as well as the development 
of pain syndromes and mood disorders such as depression(Yiu and He, 2006). Therefore, 
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developing novel therapeutic strategies for preventing this series of events of the secondary 
stage of SCI is highly prioritized. 
 
Flavonoids 
Flavonoids are in the most common and widely distributed group of plant phenolic 
compounds, occurring virtually in all plant parts, particularly the photosynthesizing plant cells. 
Meanwhile, flavonoids in food are generally responsible for colour, taste, prevention of fat 
oxidation, and protection of vitamins and enzymes.  
Flavonoids are extracted from plants that have been used for the treatment of neurovascular 
and spinal diseases for centuries in Chinese medicine, and more experience is continuously 
gained about their significant neuroprotective properties(Sang et al., 2004; Lee et al., 2012; Wang 
et al., 1997; Zhao et al., 2006). Flavonoids are hydroxylated phenolic substances and are known 
to be synthesized by plants in response to microbial infection. A number of studies show 
flavonoids compounds have anti-inflammatory(Thao et al., 2016), antioxidant(Baharfar, Azimi, 
and Mohseni, 2015), anti-tumor(Srivastava et al., 2016; Saeed et al., 2015), anti-viral(Yin et al., 
2014), anti-cardiovascular disease(Macready et al., 2014), and immunomodulatory 
effects(Sternberg et al., 2009). 
Flavonoidscontaining a 2-phenyl chromone structure are common in nature(Tsuji et al., 2013). 
They make up a large group of polyphenolic compounds that have a benzo-γ-pyrone structure 
and are ubiquitously present in plants.  According to the oxidation degree of the structure of 
the three carbon bonds (C3) and the connection position of the B ring, the flavonoid compounds 
can be classified into the following categories (Fig 1):flavones, flavonol, isoflavone, chalcone, 
aurones, flavanes, anthocyanidins, biflavone and other two-hydrogen derivatives(Gonzales et al., 
2015; Sternberg et al., 2009). Flavonoids occur as aglycones, glycosides, and methylated 
derivatives. The basic flavonoid structure is aglycone. The position of the benzenoid substituent 
divides the flavonoid class into flavonoids (2-position) and isoflavonoids (3-position). Flavonols 
differ from flavanones by a hydroxyl group at the3-position and aC2–C3 double 
bond(K.R.Narayana, 2001). Flavonoids are often hydroxylated in positions 3, 5, 7, and 2. When 
glycosides are formed, the glycosidic linkage is normally located in positions 3 or 7 and the 
carbohydrate can be L-rhamnose, D-glucose, glucorhamnose, galactose, or arabinose(Middleton, 
1984). 
 
figure 1 The basic structure of flavonoids 
 
Flavonoids have extensive biological properties thatpromote human health and help reduce 
the risk of diseases. The isoflavanglabridin, a major polyphenolic compound found in Glycyrrhiza 
glabra, inhibits low-density lipoprotein (LDL) oxidation via a mechanism involving scavenging of 
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free radicals(Fuhrman et al., 1997). Flavonoids from Green or black tea may lower blood 
cholesterol concentrations and blood pressure, thereby providing some protection against 
cardiovascular disease. Flavonoids are also known to influence the quality and stability of foods 
by acting as antioxidants(Craig, 1999; Kumar et al., 2012). Flavonoids contained in berries may 
have a positive effect against Parkinson’s disease and may help to improve memory in elderly 
people. Antihypertensive effect has been observed in hypertensive rats(Li et al., 2005). 
 
Pharmacology of flavonoids in SCI 
Flavones and Dihydroflavones 
The key source of flavones and dihydroflavones (Fig2) is the Scutellaria baicalensis Georgi 
(Huang Qin),an important medicinal herb in China. It has been widely used for the treatment of 
inflammatory diseases and ischemic stroke for thousands of years. Baicalin (7-glucuronic acid, 5, 
6-dihydroxyflavone,BC)(Fig2), a flavonoid compound isolated from Huang Qin, has been proven 
to possess anti-oxidant, anti-inflammatory, and anti-apoptotic properties. Importantly, BC can 
pass through the blood–brain barrier (BBB) into the central nervous system (CNS) and could be a 
novel and promising therapeutic agent for human spinal cord injury(Shang et al., 2006; Zhang et 
al., 2006; Gao et al., 1999). 
 
Fig 2 Structure of Flavones and Dihydroflavones: a. generic molecular structure of Flavones; 
b. generic molecular structure of Dihydroflavones; c. structure of Baicalin. 
 
Anti-inflammatory properties 
The inflammatory reaction within the spinal cord and generation of proinflammatory 
cytokines at the site of injury, such as tumor necrosis factor-α (TNF-α) and nuclear factor-κB 
(NF-κB), has been shown to be involved in regulating the precise cellular events after SCI in a SCI 
rats model(Shang et al., 2006; Smith et al., 2010; Lin et al., 2010; Zhang et al., 2009). The 
generation of inflammatory cytokines is regulated by the transcription factor NF-κB in rat models 
with different cellular inflammatory reactions(Streit et al., 1998). It was found that by treatment 
with BC, the expression of NF-κB mRNA and TNF-α mRNA significantly decreased, and the extent 
of spinal cord damage was also alleviated to some extent at the same time in a compression 
spinal cord injury rat model(Cao et al., 2010). Other studies found that intrathecalbaicalin 
significantly inhibited histone deacetylase 1 (HDAC1) phosphorylation in nerve ligation of rat 
spinal cords; which suggests that BC might directly affect the HDAC1 protein structure by 
modification at the posttranslational level to inhibit neuroinflammation in the spinal cord of rats 
with spinal nerve ligation(Cherng et al., 2014). Therefore, BC has helpful effects in treating the 
injured spinal cord. 
 




It has been shown that production of free radicals and reactive oxygen species induced by 
SCI contribute to the disruption of endothelium and the opening of the blood–spinal cord barrier 
(BSCB), whereas anti-oxidant compounds attenuate edema formation and cell injury after SCI in 
rats(Sharma et al., 2006). BC is a scavenger of free radicals in cultured human neuroblastoma 
SH-SY5Y cells (Gao et al., 1999). The BC treatment significantly reduces the increased 
malonaldehyde(MDA) values and increases the glutathione (GSH) levels after SCI in an animal 
model, suggesting that the protective effect of BC may be related to the inhibition of free radical 
and oxidant formation. 
 
Anti-apoptotic properties 
Recent studies have demonstrated that BC possesses potent anti-apoptotic properties and 
attenuates cerebral ischemia injury in rats(Shang et al., 2006; and et al., 2010). Key anti-apoptotic 
signaling molecules in neurons are Bcl-2, Bax and the Bcl-associated death promoter in transgenic 
mice(Martinou et al., 1994). BC reduces the expression of Bax and increases the expression of 
Bcl-2 compared with SCI saline-treated rats. In addition, caspase-3 is activated during the early 
phase of apoptosis and activation of caspase-3 is part of the apoptosis process by enhancing the 
cleavage of DNA, nuclear lamins, and cytoskeletal components. Taken together, these properties 




SCI results in a significant increase in lipid peroxidase, nitric oxide, TNF-α, interleukin-1β 
(IL-1β), and Bax levels, whereas expression of bcl-2 and caspase-3 are significantly reduced by 
treatment with chrysin. This shows that chrysin is a flavones containing antioxidant, and its 
anti-apoptotic property promotes the subsequent recovery of both motor and sensory functions 
via modulation of endogenous biomarkers and neuronal apoptosis to reduce the neurological 
deficits caused by SCI in a rat model of SCI(Kandhare et al., 2014). 
 
Flavonol and Dihydroflavonol 
Representative members of the flavonol and dihydroflavonol groups are rutin, quercetin, 
and Silymarin (Fig3). Rutin, a flavonoid obtained from plants, has been shown to be effective in 
conditions involving inflammation and oxidative stress. Studies show flavonoid compounds have 
anti-inflammatory, antioxidant, anti-tumor, anti-viral, anti-cardiovascular disease, and 
immunomodulatory effects(Matsunaga et al., 2000; Aruna et al., 2014; Song et al., 2015). Studies 
indicate that rutin improves spatial memory and neurological function in an Alzheimer's disease 
transgenic mouse model, and reduces neurodegeneration in the periphery of cortical injury(Xu et 
al., 2014; Rodrigues et al., 2013). A compound with anti-oxidative and anti-inflammatory 
properties such as quercetin is a potentially useful therapeutic treatment for SCI. The 
experimental results also suggest a protective role for quercetin in the bladder against 
SCI-induced tissue damage by its ability to downregulate pro-inflammatory cytokines and to 
inhibit neutrophil infiltration and apoptosis, and to balance the oxidant-antioxidant 
status(Schultke et al., 2010). Silymarin, a European herbal drug, has been used for a long time by 
patients suffering from liver diseases of different etiology. Silymarin, purified from milk thistle 
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silybummarianun, consists of a mixture of 7 flavonolignans and polyphenols. Silymarin has been 
identified in several in vitro and in vivo models as antioxidants and radical scavengers(Feher and 
Lengyel, 2012; Ramasamy and Agarwal, 2008). 
 
Fig3 Structure of Flavonol and Dihydroflavonol: a. generic molecular structure of Flavonol; b. 
molecular structure of Dihydroflavonol; c. structure of rutin; d. structure of quercetin; e. 
structure of Silymarin. 
 
Anti-inflammatory properties 
Studies show that rutin suppresses NLRP3 (NACHT, LRR, and PYD domains-containing 
protein 3) inflammasome activation and decreases levels of IL-1β, IL-18, TNF-α and reduces ROS 
and MDA productions by histopathology at the 72 h after SCI in a rat model(Zendedel et al., 
2016). Quercetin has been shown to reduce plasma levels of pro-inflammatory cytokines (TNF-α, 
IL-6, IL-1β), myeloperoxidase (MPO) levels, and ameliorates nano zinc oxide particle-induced 
nephrotoxicity in rats after SCI in an animal model(Impellizzeri et al., 2015; Schultke, Griebel, and 
Juurlink, 2010).  
 
Anti-oxidative properties 
Studies showed that rutin control oxidative stress by inhibition of NLRP3 oxidant activation 
in a rat model of SCI(Wu et al., 2016; Schroder and Tschopp, 2010). This indicates that the 
activation of the Protein 38 mitogen-activated protein kinase/inducible nitric oxide synthase 
(p38MAPK/iNOS)signaling pathway is involved in the secondary injury mechanism 
post-SCI(Lawrence et al., 2008),quercetin can regulate secondary oxidative stress following SCI by 
directly clearing oxidants and inhibiting activation of thep38MAPK/iNOS pathway in SCI rats(Wu 
et al., 2016). In another study, investigators treated mixed neuronal/glial cell cultures with 
Silymarin. The results show that Silymarin inhibits cell proliferation and protects mixed glial cell 
cultures against peroxide toxicity. Protein kinase C (PKC) or NF-kB inhibitors blocked Silymarin 
protection against H2O2 toxicity. Silymarin protected mixed cortical and spinal neuronal/glial cells 
against peroxide challenge, spinal cord neuronal/glial cell cultures from lipopolysaccharides 
(LPS)induced inflammation, and glial cell cultures and microglia from LPS stimulation or peroxide 
toxicity in primary neuronal/glial cell cultures and in vivo(Tsai et al., 2010). 





In addition, rutin can prevent SCI-induced programmed cell death in SCI rats model (Zhang 
and Ma, 2015). A study revealed that rutin reduced programmed cell death by influencing the 
down-regulation of the NLRP3 in an alcohol and cerulein-induced rat model of pancreatitis(Aruna, 
Geetha, and Suguna, 2014). Jeong et al. reported that rutin inhibited myocardial 
ischemia/reperfusion-induced apoptosis via extracellular regulated protein kinases 1/2 (ERK1/2) 
and phosphatidylinositol 3 kinase/ protein kinase B (PI3K/Akt) signaling in vitro(Jeong et al., 2009). 
Caspase 3 has been associated with apoptosis in spinal cord injury, and quercetin treatment 
counteracted apoptotic cell death as measured by immunoblotting of the cleaved caspase 3 and 
caspase 3 activity. Moreover, quercetin inhibited the phosphorylation of the c-Jun N-terminal 
kinase/stress-activated protein kinase in rats(Wei et al., 2012; Dasari et al., 2007) (JNK/SAPK)and 
p38MAPK that are involved in the inhibition of cell growth as well as the induction of apoptosis in 
an animal model(Angeloni and Hrelia, 2012; Cevik et al., 2013). 
 
Neuroprotective properties 
Rutin exhibits neuroprotective effects through antioxidative and anti-inflammatory activity. 
In vitro, rutin reduces nitric oxide and pro-inflammatory cytokine production in SH-SY5Y 
neuroblastoma cells(Wang, Wang, et al., 2012). Furthermore, rutin attenuated 
6-hydroxydopamine-induced neurotoxicity via improving antioxidant enzyme levels and reducing 
lipid peroxidation in PC-12 cells(Magalingam, Radhakrishnan, and Haleagrahara, 2013). Moreover, 
in vivo, rutin has been demonstrated to enhance the neurotrophic effect by reduction of 
macrophage inflammatory protein-2 (MIP-2) and p-Akt expression and matrix 
metallopeptidase-9activation in SCI rats(Zhang and Ma, 2015). Furthermore, rutin augments 
Basso Beattie Bresnahan scores and decreased spinal cord water content of SCI rats. Following 
quercetin treatment of 0.2 mg/kg per day, the mean values of motor activity scores and critical 
angle of inclined plane test were significantly increased that even brief exposure to quercetin had 
some neuroprotective effect in an animal model of spinal cord compression injury(Schultke et al., 
2010). 
 
Isoflavone and Dihydroisoflavone 
A representative member of the Isoflavone and Dihydroisoflavone group is Puerarin (Fig4). 
Puerarinis extracted from Radix puerariae that has been used for the treatment of neurovascular 
and spinal diseases for centuries in Chinese medicine, and its significant neuroprotective 
properties have attracted attention, particularly in the treatment of spinal ischemic damage(Sang 
et al., 2004; Xing et al., 2011). Available reports on the neuroprotective mechanisms of puerarin 
involve superoxide dismutase activity(Nwose and Ewing, 2009), lipidperoxidation, fibrinolysis, 
inflammatory responses, and cell apoptosis(Xu et al., 2005). 




Fig 4 Structure of Isoflavone and Dihydroisoflavone: a. the generic molecular structure of 
Isoflavone; b. the generic molecular structure of Dihydroisoflavone; c. structure of Puerarin. 
 
Neuroprotective properties 
Previous studies have shown a neuroprotective effect of puerarin on spinal ischemic damage 
in an animal model. Furthermore, puerarin can also increase spinal blood flow in Clinical 
observation(Zhou et al., 2006), and reduce spinal cord injury in an ischemia–reperfusion rabbit 
model. A recent study has demonstrated that puerarin reduces hypoxia inducible factor 1 and 
TNF-α levels, apoptosis, and neutrophil activation, resulting in a reduction of the infarct volume 
in ischemia–reperfusion brain injury in rats(Chang et al., 2009). The neuroprotective mechanism 
of puerarin against spinal ischemia–reperfusion injury may involve the upregulation of 
thioredoxin mRNA and reduction of apoptosis in the spinal cord ischemia-reperfusion injury rat 
model(Tian et al., 2011). The neurological deficit caused by SCI/ reperfusion injury (RI) was 
associated with glutamate release and elevation of glutamate RNA expression in acute spinal cord 




The representative member of the chalcone group is Safflower Yellow (SY; Fig5), which is 
extracted from the flowers of the plant safflower (Carthamus tinctorius) and in traditional 
Chinese medicine it has been extensively used for the treatment of cardio-cerebrovascular 
diseases. Hydroxysafflor yellow A (HSYA) (Fig5), which is the main chemical component of the 
safflower yellow pigments, has been demonstrated to have potent antioxidative effect in vitro(Jin, 
Li, and Wu, 2004). SY can promote blood circulation, remove blood stasis, and thereby improve 
capillary circulation at the site of tissue injury. Additionally, a previous study indicated that SY 
alleviates the injured tendon adhesion and inflammatory reaction and promotes the repair of 
injured tendons(Shan et al., 2010). Recent studies revealed that HSYA could alleviate 
ischemia-reperfusion injury of the lung, heart and brain via scavenging of free radicals(He et al., 
2008; Wei et al., 2005). 
 




Fig 5 Structure of chalcone: a. the generic molecular structure of chalcone; b. structure of 
Safflower yellow (SY); c. structure of Hydroxysafflor yellow A (HSYA). 
 
Anti-inflammatory properties 
IL-8 is an important cytokine, which plays a key role in the inflammation response(Kunihara 
et al., 2000). One study shows that SYinhibits IL-8 expression and the inflammatory response 




Safflower and its extracts play an important role in of inhibiting lipid peroxidation and 
clearing oxygen free radicals in rats(Ma et al., 2015). Safflower injection can significantly activate 
glutathione peroxidase and superoxide Dismutase (SOD) and decrease MDA levels in myocardium 
ischemia reperfusion injury. These results indicate that SY could play an important role in spinal 
cord protection by relieving lipid peroxidation in a rabbit spinal cord ischemia reperfusion injury 
animal model(Zhou et al., 2013). 
 
Anti-apoptotic properties 
A recent study confirmed that activation of caspase-3 expression correlates with levels of 
cell apoptosis after SCI, suggesting that caspase-3 could be used as biochemical index in assessing 
post-ischemic spinal cord injury in the clinic(Lin et al., 2012). The results demonstrate that 
inhibiting caspase-3 expression may represent a mechanism by which SY confers protection 
against SCI in a rabbit spinal cord ischemia reperfusion injury animal model(Zhou et al., 2013). 
HSYA significantly reduced the number of apoptotic cells in the anterior horn of the spinal cord. 
This protective effect of HSYA against neuronal apoptosis may be related to its antioxidative effect 
because a major mechanism of ischemia/reperfusion induced apoptosis is attributed to ROS 
release in a rabbit spinal cord ischemia reperfusion injury animal model (Shan et al., 2010). 
 




One study provided direct in vivo evidence that HSYA confers neuroprotection through its 
antioxidative action. Moreover, the neuroprotective effect of HSYA might also be attributed to its 
inhibition of thrombosis formation and platelet aggregation, its regulation of the prostaglandin 
I2/thromboxane ratio and blood rheological changes, as well as its suppression of inflammatory 




A typical flavane is the (-)-Epigallocatechingallate (EGCG) (Fig6), the most abundant active 
component of the tea catechins and thought to be responsible for most of the biological activity 
of green tea extracts(Kimura et al., 2002). EGCG is known for its potent antioxidant and 
anti-inflammatory properties(Kim et al., 2003). EGCG also has been shown to have some 
protective effects against neuronal damage. A recent study shows that EGCG could attenuate 
neuronal apoptosis and improve locomotor function after SCI in rats(Khalatbary and Ahmadvand, 
2011). 
 




A recent study showed that MPO activity significantly decreased in EGCG-treatment groups. 
Attenuated TNF-α, IL-1β, Nitrotyrosine, iNOS, cyclooxygenase-2 (COX-2), and poly-ADP-ribose 
polymerase (PARP) expression was obseved in the EGCG treated rats. Also, EGCG attenuated 
myelin degradation. It appears that EGCG may be effective in protecting rat spinal cord neurons 
from secondary damage by modulating the inflammatory response in a spinal cord trauma rat 
model(Khalatbary and Ahmadvand, 2011). 
 
Antioxidant properties 
Another study showed that EGCG modulates the levels of O2−and SOD. In addition, the MDA 
levels in the EGCG treatment groups were significantly lower than those in the trauma group 
after SCI in an SCI rat model(F. Deng, 2011; Khalatbary et al., 2010). 
 
Anti-edema properties 
The results of a different study imply that EGCG has an anti-edema effect after acute SCI. 
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The anti-edema effect could be the result of down-regulation of the expression of Aquaporin-4 
(AQP4) protein levels. Also EGCG may reduce astrogliosis after SCI through down-regulation the 
expression of glial fibrillary acidic protein (GFAP) levels in a SCI rat model(Ge et al., 2013). 
 
Anti-apoptotic properties 
EGCG inhibits the expression of the pro-apoptotic protein Bax and increases that of the 
anti-apoptotic protein Bcl- 2, thereby providing a molecular mechanism for the neuroprotective 
activity of EGCG. The number of TUNEL-positive cells at the spinal lesion site of EGCG-treated rats 
was significantly lower than that in the trauma group in the contusive spinal cord injury rat 
model(Khalatbary et al., 2010). 
 
Neuroprotective properties 
Intravenous infusion of EGCG in acute or chronic phase following SCI in rats promotes 
significant locomotor recovery as measured by the standard motor tests and The Louisville Swim 
Scale tests. EGCG-treated SCI animals significantly improve on the tactile allodynia reflex and 
mechanical nociception threshold(Renno et al., 2014). Moreover, 4 weeks after SCI, the 
expression of neurotrophic factors BDNF and GDNF in the spinal cords of EGCG-treated animals 
were higher than in the control group(Tian, Han, et al., 2013). Treatment with EGCG modulates 
the expression of growth associated protein-43 (GAP-43) and GFAP levels and protects neurons 




Anthocyanins (Fig7) are natural pigments belonging to the flavonoid family and are present 
in fruits and vegetables. They are known to have powerful antioxidant effects, anti-carcinogenic 
properties and potent cardioprotective effects. They can also inhibit inflammation(Romero et al., 
2008; Steed and Truong, 2008; Xu and Chang, 2009). Among anthocyanins, cyanidin 
3-O-β-glucoside (C3G) (Fig7) has the highest protective effects as a scavenger of active oxygen 
species in hepatic ischemia-reperfusion damage and cerebral ischemia models. Two studies were 
published on the pre-/post-treatment of C3G which showed significant improvement of 
neurological recovery and a decrease of infarction volume in cerebral ischemia rat models(Kang 
et al., 2006; Shin, Park, and Kim, 2006). Bog bilberry is a low-growing deciduous shrub of the 
Ericaceae family of plants. Berries of the Ericaceae family are known to contain organic acids, 
vitamins, glycosides, and anthocyanins and have been reported to have antioxidant activity. Bog 
bilberry anthocyanin extract (BBAE) (Fig7)has been shown to have antioxidant activity(Kim et al., 
2009). 
 
Fig 7 Structure of Anthocyanins: a. generic molecular structure of Anthocyanins; b. structure 
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of cyanidin 3-O-β-glucoside (C3G); c. structure of Bog bilberry anthocyanin extract (BBAE). 
 
Anti-inflammatory properties 
BBAE treatment reduced the expression the key cytokines TNF-a, IL-1β, and IL-6 in a rat 
model of SCI(Wang, Ma, et al., 2012). 
Antioxidant properties 
The main therapeutic role of C3G is the scavenger of ROS. C3G significantly reduced the 




In addition, C3G decreased the lesion volume and protected motor neurons in the anterior 
horn of lesion peripheries 14 days after SCI in rats(Kim et al., 2011).These observations show that 
the BBAE therapy could exert protective effect on the neurons and promotes neuronal survival 
after SCI. In addition, BBAE can reduce myelin axonal loss, glial scars formation, and astrocyte 




A representative member of the biflavonoid group (Fig 8) is the Ginkgo biloba extract 
(EGb761),a complex mixture of ingredients with broad pharmacological effects on the CNS. 
Recent studies using the SCI model revealed that EGb761 is involved in the protection of spinal 
cord neurons in ischemic injury in vivo(Mechirova et al., 2009) and hydrogen peroxide-induced 
spinal cord neuronal death in vitro. The neuroprotective effects of EGb761 include scavenging 
free radicals, lowering oxidative stress, reducing neural damage, preventing platelet aggregation, 
and anti-inflammation(Wang, Ma, et al., 2012; Jiang et al., 2009; Kotakadi et al., 2008). 
Ginkgolides B is the active constituent that has attracted the most attention in recent years. 
Ginkgolide B can improve hemorrhage, edema, necrosis, and inflammatory cell infiltrates in the 
injured spinal cord(Zhang et al., 2016). 
 
Fig 8 Structure of biflavonoid: a. generic molecular structure of biflavonoid; b. structure of 
Ginkgo biloba extract (EGb761); c. structure of ginkgolides B. 
 
Antioxidant properties 
Ginkgo biloba extract (GBE) ameliorated the down-regulation of SOD and produced a 
significant reduction of MDA levels in spinal cord ischemia/reperfusion rabbits(Fan, Wang, and 
Cheng, 2006). MP and Ginkgo biloba treatments significantly decreased MDA levels. Furthermore, 
MP and Ginkgo biloba has a protective effect against ischaemic spinal cord injury via their 
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antioxidant effects in rat model(Koc et al., 1995). The research demonstrated that iNOS 
expression was upregulated after SCI. EGb761 can suppress iNOS expression and prevent 
neuronal death in SCI rats(Ao et al., 2006). 
 
Anti-apoptotic properties 
GBE was able to reduce the number of apoptotic cells, demonstrating its ability to reduce 
apoptosis. Levels of bcl-2 were up-regulated by GBE. The up-regulation of Bax was greatly 
diminished by GBE in rabbits). Analysis of apoptosis results and caspase-3 staining demonstrats 
that cell apoptosis was increased at 1–14 days post injury (DPI). At 7 DPI, the quantity of 
apoptotic cells significantly decreased in the EGb761-treated group in rats with acute spinal cord 
contusion injury(Yan et al., 2016). GBE inhibited nerve cell apoptosis via the mitochondrial 
caspase-dependent and caspase-independent pathways after spinal cord ischemia–reperfusion in 
rabbits. Furthermore, GBE could reduce levels of caspase-9 and apoptosis-inducing factor in the 
cytoplasm and serum(Cheng et al., 2011). 
 
Neuroprotective properties 
In a spinal cord ischemia/reperfusion study in rabbits, GBE improved the motor score and 
reduced lipid peroxidation and apoptosis(Fan, Wang, and Cheng, 2006). EGb761 protected spinal 
cord neurons against these insults indicating that such protection is mediated, at least in part, 
through the inhibition of cytosolic phospholipase A2 (cPLA2). The ERK1/2 signaling pathway 
mediated the activation of cPLA2, and treatment with EGb761 significantly decreased ERK1/2 
phosphorylation. Thus, EGb761 may be considered as a potential therapeutic agent aiming at 
reducing secondary degeneration(Zhao et al., 2011). 
 
Conclusion and future studies 
In this paper, we reviewed therapeutic effects of different kinds of flavonoids (Fig 9), which 
mainly have anti-inflammatory, antioxidant, anti apoptosis and neuroprotective properties in 
treatment of SCI. The anti-inflammatory properties are mainly due to inhibiting the production of 
inflammatory cytokines. Flavonoids can reduce expression of NF-κB mRNA and TNF-α mRNA and 
decrease of IL-1β, IL-8, IL-18, and TNF- levels. The antioxidative property of flavanoids in SCI is 
through reducing ROS, MDA, and iNOS activity, increasing the GSH levels, and blocking H2O2 
toxicity and LPS stimulation. The anti-edema effect of flavanoid treatment after acute SCI is via 
down-regulation of the expression of AQP4 protein and GFAP proteins. Anti-apoptotic properties 
act mainly through the reduction of the expression of Bax, increase of the expression of Bcl-2 
levels, and inhibition of caspase-3 expression and caspase-3 activity. Neuroprotective properties 
of the flavanoids after SCI work by reducing myelin axonal loss, glial scars formation, and 
astrocyte proliferation after SCI. Moreover, flavanoids could increase neurotrophic factors BDNF 
and GDNF in the spinal cords and decrease deactivationof growth signaling pathways. 
Spinal cord injury may lead to neurological complications and eventually to paraplegia or 
quadriplegia. However, there is no effective treatment available, the main reason may be the 
complex pathophysiological mechanisms of spinal cord injury, and the secondary damage 
induced by a series of cellular and molecular events. Fortunately, flavonoids show promising 
therapeutic potential in spinal cord injury. Nevertheless, the molecular mechanisms involved in 
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TCM treatments still remain unclear, which require further research to reveal these. We hope 
that the TCM treatment combined with other treatments can treat and repair spinal cord injury 
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